Get started
Author

Faith M Young

B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximab
2004 · R. John Looney, Jennifer H. Anolik, et al. · Arthritis & Rheumatism · 776
The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus
2003 · Jennifer H. Anolik, Debbie Campbell, et al. · Arthritis & Rheumatism · 429
RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development.
1993 · J Chen, R Lansford, et al. · Proceedings of the National Academy of Sciences · 401
Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus
1993 · Jianzhu Chen, Mary Trounstine, et al. · International Immunology · 393
VDJ recombination
1992 · Frederick W Alt, Eugene M Oltz, et al. · Immunology Today · 325
A class switch control region at the 3′ end of the immunoglobulin heavy chain locus
1994 · Michel Cogné, Rusty Lansford, et al. · Cell · 269
The expression of Vpre-B/λ5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice
1994 · Hajime Karasuyama, Antonius Rolink, et al. · Cell · 235
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma
2011 · Jonathan W. Friedberg, Julie M. Vose, et al. · Blood · 190
Influence of immunoglobulin heavy- and light-chain expression on B-cell differentiation.
1994 · F Young, B Ardman, et al. · Genes & Development · 189
PDF
Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus.
1993 · J. Chen, F. Young, et al. · The EMBO Journal · 188
PDF
B cell development in mice that lack one or both immunoglobulin kappa light chain genes.
1993 · J. Chen, M. Trounstine, et al. · The EMBO Journal · 185
PDF
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a “vaccinal effect” of rituximab
2009 · Shannon P. Hilchey, Ollivier Hyrien, et al. · Blood · 151
PDF
Autoantibodies encoded by the most Jh-proximal human immunoglobulin heavy chain variable region gene.
1989 · T Logtenberg, F M Young, et al. · The Journal of Experimental Medicine · 107
PDF
Susceptibility to Autoimmunity and B Cell Resistance to Apoptosis in Mice Lacking Androgen Receptor in B Cells
2009 · Saleh Altuwaijri, Kuang-Hsiang Chuang, et al. · Molecular Endocrinology · 82
A phase I pharmacokinetic and pharmacodynamic study of AMG 479, a fully human monoclonal antibody against insulin-like growth factor type 1 receptor (IGF-1R), in advanced solid tumors
2007 · A. W. Tolcher, M. L. Rothenberg, et al. · Journal of Clinical Oncology · 76
Tetracyclines inhibit activated B cell function
2001 · Igor I. Kuzin, Jennifer E. Snyder, et al. · International Immunology · 63
Constitutive Bcl-2 Expression during Immunoglobulin Heavy Chain–Promoted B Cell Differentiation Expands Novel Precursor B Cells
1997 · Faith Young, Emiko Mizoguchi, et al. · Immunity · 54
PDF
Probing immune functions in RAG-deficient mice
1994 · Jianzhu Chen, Yoichi Shinkai, et al. · Current Opinion in Immunology · 51
IL-2 receptor α chain expression during early B lymphocyte differentiation
1994 · Jianzhu Chen, Averil Ma, et al. · International Immunology · 50
Molecular analysis of a germ line-encoded idiotypic marker of pathogenic human lupus autoantibodies.
1990 · F Young, L Tucker, et al. · The Journal of Immunology · 49
Individual VH genes detected with oligonucleotide probes from the complementarity-determining regions.
1990 · T Guillaume, D B Rubinstein, et al. · The Journal of Immunology · 48
9G4 Autoreactivity Is Increased in HIV-Infected Patients and Correlates with HIV Broadly Neutralizing Serum Activity
2012 · James J. Kobie, Danielle C. Alcena, et al. · PLoS ONE · 43
PDF
CD40 expression and function in murine B cell ontogeny
1996 · Emanuela Castigli, Faith Young, et al. · International Immunology · 25
Bendamustine, Bortezomib and Rituximab in Patients (pts) Relapsed/Refractory Indolent and Mantle Cell Non-Hodgkin Lymphoma (NHL): a Multicenter Phase II Clinical Trial.
2009 · Jonathan W. Friedberg, Julie M. Vose, et al. · Blood · 20
Truncated immunoglobulin Dμ causes incomplete developmental progression of RAG-deficient pro-B cells
2002 · Barbara A Malynn, Albert C Shaw, et al. · Molecular Immunology · 14
Works count: 53
Citation count: 4,469
H-index: 23
I10-index: 26
Year
Topic
Type